Oral valgancyclovir versus intravenous gancyclovir for cytomegalovirus prophylaxis in kidney transplant recipients.
暂无分享,去创建一个
A. Pacsa | S. Essa | K. Johny | M. Halim | T. Al-Otaibi | M. Abraham | T. Said | M. Nampoory | M. Al-Mousawi | P. Nair | N. Madi | N. Fahim